HFA Premium Access

Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis

Congress Presentation

About the speaker

Doctor Jesus Hernando Diaz Acevedo

University of Los Andes, Bogota (Colombia)
1 follower

37 more presentations in this session

Position and cardiorenal mechanisms of uromodulin in heart failure

Speaker: Doctor L. Emmens (Groningen, NL)

Thumbnail

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Speaker: Doctor E. Barge Caballero (A Coruna, ES)

Thumbnail

Hepatic T1-time is a strong and independent predictor of cardiovascular outcome in all-comers referred for cardiac magnetic resonance imaging

Speaker: Doctor K. Mascherbauer (Vienna, AT)

Thumbnail

Virtual management of HF outpatient during COVID-19 pandemic period: a comparison with traditional follow up

Speaker: Doctor S. Prosperi (Rome, IT)

Thumbnail

Longitudinal analysis of ejection fraction in heart failure with reduced ejection fraction patients: pharmacological treatment effects

Speaker: Mr A. Hernandez-Vicente (Murcia, ES)

Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 4

Speakers: Doctor J. Diaz Acevedo, Doctor L. Emmens, Doctor E. Barge Caballero, Doctor K. Mascherbauer, Doctor S. Prosperi...
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Related content

ESC Premium Access

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry

27 August 2021

ESC Premium Access

Comparing Rivaroxaban and Apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

27 August 2021

ESC Premium Access

The practicalities of drug treatment in heart failure - Chat Moderator.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk